Boosting Immunotherapy in Breast Cancer: Researchers at the Jules Bordet Institute Publish in Nature Medicine
This clinical study, conducted by researchers at the Jules Bordet Institute, focused on so-called "cold" breast cancers—tumours that are poorly recognized by the immune system. Immunotherapy is most effective when tumours are already "hot", meaning they naturally attract immune cells capable of attacking cancer cells. The NeoCheckRay study explored an innovative approach: using highly targeted radiotherapy to modify the tumour microenvironment…
(read more)